NA
Narasaiah Arigela
About Narasaiah Arigela
Data last updated:
Narasaiah Arigela is a Cfo at Keimed Private Limited (since 2015), Director at Sanjeevani Pharma Distributors Private Limited (since 2016) and Director at Dhruvi Healthcare Private Limited (since 2022), and holds 18 more current directorships. The companies operate in Healthcare, Pharma and E-Commerce. The 19 current companies with reported revenue have a combined latest revenue of ₹18,049 Cr; the largest is Keimed Private Limited at ₹14,790 Cr (FY 2026). Earlier, Narasaiah Arigela was a Nominee Director at Anila Medical Private Limited (2021–2025) and Nominee Director at Vasu Pharma Distributors Hyd Private Limited (from 2020) and 2 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Keimed Private Limited U72200TN2000PTC179280 | Cfo | 31 Jan 2015 | 2000 | ₹14,790 Cr (FY 2026) | Active |
 Sanjeevani Pharma Distributors Private Limited U74900TG2015PTC101507 | Director | 31 Mar 2016 | 2015 | ₹1,077 Cr (FY 2025) | Active |
| Dhruvi Healthcare Private Limited U51909GJ2022PTC129886 | Director | 07 Mar 2022 | 2022 | ₹634 Cr (FY 2025) | Active |
| Adeline Pharmaceuticals Private Limited U51397WB2022PTC252369 | Director | 09 Jan 2024 | 2022 | ₹357 Cr (FY 2025) | Active |
| Atc Medicare Private Limited U51909GJ2022PTC130084 | Director | 14 Mar 2022 | 2022 | ₹224 Cr (FY 2025) | Active |
| Vasu Vaccines And Speciality Drugs Hyd Private Limited U51909TG2022PTC160701 | Director | 09 Jan 2024 | 2022 | ₹215 Cr (FY 2025) | Active |
| Sri Venkateswara Galaxy Medical Distributors Private Limited U51909AP2021PTC120262 | Director | 09 Jan 2024 | 2021 | ₹207 Cr (FY 2025) | Active |
| Lifeline Pharma Distributors Private Limited U51909DL2022PTC396642 | Director | 13 Apr 2022 | 2022 | ₹118 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Anila Medical Private Limited U51909MP2020PTC051475 | Nominee Director | 04 Aug 2021 | 2020 | ₹72.79 Cr (FY 2025) | Active |
| Vasu Pharma Distributors Hyd Private Limited U51909TG2017PTC121037 | Nominee Director | 26 Aug 2020 | 2017 | ₹108 Cr (FY 2023) | Amalgamated |
| Venkatasai Agencies Hyd Private Limited U51909TG2017PTC121099 | Nominee Director | 26 Aug 2020 | 2017 | ₹73.45 Cr (FY 2023) | Amalgamated |
 Shanbalaji Pharma Private Limited U51909TG2018PTC169180 | Nominee Director | 22 Aug 2022 | 2018 | ₹51.20 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Narasaiah Arigela
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Narasaiah Arigela
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Narasaiah Arigela
Narasaiah Arigela currently holds 21 directorships: Keimed Private Limited (Cfo, since 31 Jan 2015, revenue ₹14,790 Cr (FY 2026)); Sanjeevani Pharma Distributors Private Limited (Director, since 31 Mar 2016, revenue ₹1,077 Cr (FY 2025)); Dhruvi Healthcare Private Limited (Director, since 07 Mar 2022, revenue ₹634 Cr (FY 2025)); Adeline Pharmaceuticals Private Limited (Director, since 09 Jan 2024, revenue ₹357 Cr (FY 2025)); Atc Medicare Private Limited (Director, since 14 Mar 2022, revenue ₹224 Cr (FY 2025)); and 16 more.
Narasaiah Arigela was first appointed on 31 Jan 2015 as Cfo at Keimed Private Limited. The most recent appointment on record is 23 Apr 2025 at Emmarlink Distributors Private Limited.
The 19 current companies of Narasaiah Arigela that report revenue have a combined latest revenue of ₹18,049 Cr: Keimed Private Limited ₹14,790 Cr (FY 2026); Sanjeevani Pharma Distributors Private Limited ₹1,077 Cr (FY 2025); Dhruvi Healthcare Private Limited ₹634 Cr (FY 2025); Adeline Pharmaceuticals Private Limited ₹357 Cr (FY 2025); Atc Medicare Private Limited ₹224 Cr (FY 2025); and 14 more.
Narasaiah Arigela held 4 earlier board appointments: Anila Medical Private Limited (Nominee Director, 04 Aug 2021 to 15 Apr 2025); Vasu Pharma Distributors Hyd Private Limited (Nominee Director, from 26 Aug 2020); Venkatasai Agencies Hyd Private Limited (Nominee Director, from 26 Aug 2020); Shanbalaji Pharma Private Limited (Nominee Director, from 22 Aug 2022).
The current boards of Narasaiah Arigela's companies include Arvind Kumar Venkat (Keimed Private Limited), Gaurav Chaturvedi (Keimed Private Limited), Madhu Balla (Keimed Private Limited), Pankaj Patwari (Keimed Private Limited), Puansh Kamineni (Keimed Private Limited), Raj Shankar (Keimed Private Limited), among others.